BI
ENTX icon

BVF Inc’s Entera Bio ENTX Stock Holding History

BVF Inc’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
+2,425,000
New +$3.03M 0.11% 42

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

BVF Inc's ENTX Position: Q2 2026 in Review

BVF Inc opened a new position in Entera Bio (ENTX) in Q2 2026: 2,425,000 shares worth $4.29M. The stake represents 0.11% of the portfolio and ranks #42 among its holdings.

27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • BVF Inc held 2,425,000 shares of Entera Bio worth $4.29M as of Q2 2026.
  • Entera Bio was a new BVF Inc position in Q2 2026.
  • Entera Bio made up 0.11% of BVF Inc's portfolio in Q2 2026, its #42 holding.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on BVF Inc's 13F filing for Q2 2026, filed 14 Aug 2026.